ABBOTT SPECTRUM(R) LIQUID CREATININE REAGENT— 510(k) K873310

Name: FDA 510(k) clearance K873310
Creator: U.S. Food and Drug Administration
Published: 1987-09-02

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K873310 for ABBOTT SPECTRUM(R) LIQUID CREATININE REAGENT, Substantially Equivalent on 1987-09-02. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code CGX
Device class: Class 2
Regulation: 21 CFR 862.1225
Advisory panel: Clinical Chemistry
Date received: 1987-08-18
Decision date: 1987-09-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irving, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CGX

view all

K252206 — Nova Allegro UACR Assay, Nova Allegro Analyzer2026-01-09
K251058 — Tru Kidney Health Test Panel; Tru Analyzer2025-11-26
K242685 — Atellica® CH Creatinine_3 (Crea3)2024-12-04
K221813 — Nova Allegro UACR Assay, Nova Allegro Analyzer2024-11-19
K210452 — Creatinine22022-03-22

More clearances from Abbott Laboratories

view all

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.